Gneb^®

Therapeutic Segment:
Anti-hypertensive

Generic Name:
Nebivolol Hydrochloride

Description:
Nebivolol is a racemate composed of d-Nebivolol & l-Nebivolol with the stereochemical designations of [SRRR]-Nebivolol and [RSSS]¬Nebivolol, respectively. Gneb as tablets for oral administration contains Nebivolol hydrochloride equivalent to 2.5, 5, 10, and 20 mg of Nebivolol base.

Indication:
Nebivolol is a beta-adrenergic blocking agent indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. Hypertension: Treatment of essential hypertension. Chronic heart failure (CHF): Treatment of stable mild and moderate chronic heart failure in addition to standard therapies in elderly patients 70 years old or above. Gneb(Nebivolol) may be used alone or in combination with other anti-hypertensive agents.

Formulation: